Department of Experimental Medicine, University of Rome "La Sapienza," Rome, Italy.
Service of Pharmacovigilance, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
J Clin Endocrinol Metab. 2020 Sep 1;105(9). doi: 10.1210/clinem/dgaa336.
We compared the efficacy, safety, and effect of 45-day isocaloric very-low-calorie ketogenic diets (VLCKDs) incorporating whey, vegetable, or animal protein on the microbiota in patients with obesity and insulin resistance to test the hypothesis that protein source may modulate the response to VLCKD interventions.
Forty-eight patients with obesity (19 males and 29 females, homeostatic model assessment (HOMA) index ≥ 2.5, aged 56.2 ± 6.1 years, body mass index [BMI] 35.9 ± 4.1 kg/m2) were randomly assigned to three 45-day isocaloric VLCKD regimens (≤800 kcal/day) containing whey, plant, or animal protein. Anthropometric indexes; blood and urine chemistry, including parameters of kidney, liver, glucose, and lipid metabolism; body composition; muscle strength; and taxonomic composition of the gut microbiome were assessed. Adverse events were also recorded.
Body weight, BMI, blood pressure, waist circumference, HOMA index, insulin, and total and low-density lipoprotein cholesterol decreased in all patients. Patients who consumed whey protein had a more pronounced improvement in muscle strength. The markers of renal function worsened slightly in the animal protein group. A decrease in the relative abundance of Firmicutes and an increase in Bacteroidetes were observed after the consumption of VLCKDs. This pattern was less pronounced in patients consuming animal protein.
VLCKDs led to significant weight loss and a striking improvement in metabolic parameters over a 45-day period. VLCKDs based on whey or vegetable protein have a safer profile and result in a healthier microbiota composition than those containing animal proteins. VLCKDs incorporating whey protein are more effective in maintaining muscle performance.
我们比较了含乳清、植物或动物蛋白的 45 天等热量极低热量生酮饮食(VLCKD)对肥胖和胰岛素抵抗患者肠道微生物群的疗效、安全性和影响,以检验蛋白源可能调节 VLCKD 干预反应的假设。
48 名肥胖患者(19 名男性和 29 名女性,稳态模型评估(HOMA)指数≥2.5,年龄 56.2±6.1 岁,体重指数 [BMI] 35.9±4.1kg/m2)被随机分配到三种 45 天等热量 VLCKD 方案(≤800kcal/天),分别含乳清、植物或动物蛋白。评估了人体测量指标、血液和尿液化学指标(包括肾脏、肝脏、葡萄糖和脂质代谢参数)、身体成分、肌肉力量和肠道微生物群的分类组成。还记录了不良事件。
所有患者的体重、BMI、血压、腰围、HOMA 指数、胰岛素以及总胆固醇和低密度脂蛋白胆固醇均降低。摄入乳清蛋白的患者肌肉力量改善更明显。动物蛋白组肾功能标志物略有恶化。摄入 VLCKD 后,厚壁菌门的相对丰度降低,拟杆菌门的相对丰度增加。在摄入动物蛋白的患者中,这种模式不太明显。
VLCKD 在 45 天内可显著减轻体重并显著改善代谢参数。基于乳清或植物蛋白的 VLCKD 比含动物蛋白的 VLCKD 具有更安全的特征,并导致更健康的微生物群落组成。摄入乳清蛋白的 VLCKD 更有效地维持肌肉性能。